Filing Details

Accession Number:
0001493152-22-007754
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-03-25 16:15:22
Reporting Period:
2022-03-24
Accepted Time:
2022-03-25 16:15:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
876343 Lineage Cell Therapeutics Inc. LCTX Biological Products, (No Disgnostic Substances) (2836) 943127919
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1509725 H. Michael Mulroy C/O Lineage Cell Therapeutics
2173 Salk Avenue, Suite 200
Carlsbad CA 92008
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares, No Par Value Acquisiton 2022-03-24 7,000 $1.40 258,555 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported is a weighted average. The shares were purchased in multiple transactions at prices ranging from not less than $1.40 to not more than $1.41. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range.